{"date":"2026-09-14","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6431-2026-09-14-1910-18qey81","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-09-14","time":"19:10:51","subject":"依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第二款及第三款公告申報","clause":"第23款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-09-14 19:10，「依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第二款及第三款公告申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6431-2026-09-14-1910-j6swd8","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-09-14","time":"19:10:19","subject":"依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第一款公告申報","clause":"第23款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-09-14 19:10，「依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第一款公告申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-09-14-1750-7o0cmw","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-09-14","time":"17:50:31","subject":"代子公司:Hong Kong Chlitina International Limited、(BVI) Chlitina International Limited及(BVI) ChlitinaGroup Limited等子公司公告決議配發現金股息之相關事宜","clause":"第14款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-09-14 17:50，「代子公司:Hong Kong Chlitina International Limited、(BVI) Chlitina」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-09-14-1742-1iqdg8t","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-09-14","time":"17:42:08","subject":"本公司新藥CBL-514注射劑之樞紐三期臨床試驗CBL-0302向美國FDA申請之試驗變更案已通過FDA IND 30天審閱期。","clause":"第10款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-09-14 17:42，「本公司新藥CBL-514注射劑之樞紐三期臨床試驗CBL-0302向美國FDA申請之試驗變更案已通過FDA IND 30天」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-09-14-1648-lrkgsj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-09-14","time":"16:48:21","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-09-14 16:48，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-09-14-1634-lrkgsj","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-09-14","time":"16:34:26","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-09-14 16:34，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-09-14-1614-r9hb3p","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-09-14","time":"16:14:07","subject":"本公司受統一證券邀請舉辦線上公開法人說明會","clause":"第12款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-09-14 16:14，「本公司受統一證券邀請舉辦線上公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-09-14-1556-1bi2fou","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-09-14","time":"15:56:38","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-09-14 15:56，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-09-14-1555-h25q7c","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-09-14","time":"15:55:02","subject":"公告本公司開發治療思覺失調症之505(b)(2)新藥AX251之第一期臨床試驗完成首位受試者入案(First Patient In)","clause":"第44款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-09-14 15:55，「公告本公司開發治療思覺失調症之505(b)(2)新藥AX251之第一期臨床試驗完成首位受試者入案(First Patie」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-09-14-1532-1jsiq8w","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-09-14","time":"15:32:19","subject":"公告本公司現金增資股款催繳期間屆滿暨股票發放事宜","clause":"第53款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-09-14 15:32，「公告本公司現金增資股款催繳期間屆滿暨股票發放事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-09-14-0657-rfugyc","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-09-14","time":"06:57:28","subject":"公告本公司財務主管、公司治理主管及發言人異動","clause":"第8款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-09-14 06:57，「公告本公司財務主管、公司治理主管及發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}